These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 12065772)

  • 1. Mucinous and nonmucinous appendiceal adenocarcinomas: different clinicopathological features but similar genetic alterations.
    Kabbani W; Houlihan PS; Luthra R; Hamilton SR; Rashid A
    Mod Pathol; 2002 Jun; 15(6):599-605. PubMed ID: 12065772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of loss of heterozygosity for tumor-suppressor genes can accurately classify and predict the clinical behavior of mucinous tumors arising from the appendix.
    Maheshwari V; Tsung A; Lin Y; Zeh HJ; Finkelstein SD; Bartlett DL
    Ann Surg Oncol; 2006 Dec; 13(12):1610-6. PubMed ID: 17009159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic alterations in goblet cell carcinoids of the vermiform appendix and comparison with gastrointestinal carcinoid tumors.
    Stancu M; Wu TT; Wallace C; Houlihan PS; Hamilton SR; Rashid A
    Mod Pathol; 2003 Dec; 16(12):1189-98. PubMed ID: 14681318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of chromosome 18q and DPC4 (Smad4) mutations in appendiceal adenocarcinomas.
    Maru D; Wu TT; Canada A; Houlihan PS; Hamilton SR; Rashid A
    Oncogene; 2004 Jan; 23(3):859-64. PubMed ID: 14647445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. K-ras activation occurs frequently in mucinous adenocarcinomas and rarely in other common epithelial tumors of the human ovary.
    Enomoto T; Weghorst CM; Inoue M; Tanizawa O; Rice JM
    Am J Pathol; 1991 Oct; 139(4):777-85. PubMed ID: 1656759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-genome allelotyping identified distinct loss-of-heterozygosity patterns in mucinous ovarian and appendiceal carcinomas.
    Feltmate CM; Lee KR; Johnson M; Schorge JO; Wong KK; Hao K; Welch WR; Bell DA; Berkowitz RS; Mok SC
    Clin Cancer Res; 2005 Nov; 11(21):7651-7. PubMed ID: 16278384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetic evidence supporting the clonality and appendiceal origin of Pseudomyxoma peritonei in women.
    Szych C; Staebler A; Connolly DC; Wu R; Cho KR; Ronnett BM
    Am J Pathol; 1999 Jun; 154(6):1849-55. PubMed ID: 10362811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of microsatellite instability, K-ras gene mutation and p53 protein overexpression in intrahepatic cholangiocarcinoma.
    Isa T; Tomita S; Nakachi A; Miyazato H; Shimoji H; Kusano T; Muto Y; Furukawa M
    Hepatogastroenterology; 2002; 49(45):604-8. PubMed ID: 12063950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical expressions of cytokeratins, mucin core proteins, p53, and neuroendocrine cell markers in epithelial neoplasm of appendix.
    Yajima N; Wada R; Yamagishi S; Mizukami H; Itabashi C; Yagihashi S
    Hum Pathol; 2005 Nov; 36(11):1217-25. PubMed ID: 16260276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical and mutational analyses of beta-catenin, Ki-ras, and p53 in two subtypes of colorectal mucinous carcinoma.
    Ikeda S; Shimizu Y; Fujimori M; Ishizaki Y; Kurihara T; Ojima Y; Okajima M; Asahara T
    Clin Cancer Res; 2003 Nov; 9(15):5660-5. PubMed ID: 14654549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of BAT-26 as an indicator of microsatellite instability in gallbladder carcinomas.
    Saetta A; Koilakou SV; Michalopoulos NV; Davaris PS
    Hepatogastroenterology; 2003; 50(54):1799-802. PubMed ID: 14696408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, histopathological, cytogenetic and prognostic differences between mucinous and nonmucinous colorectal adenocarcinomas.
    Enríquez JM; Díez M; Tobaruela E; Lozano O; Domínguez P; González A; Mugüerza JM; Ratia T
    Rev Esp Enferm Dig; 1998 Aug; 90(8):563-72. PubMed ID: 9780789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and clinicopathological features of appendiceal mucinous neoplasms.
    Yanai Y; Saito T; Hayashi T; Akazawa Y; Yatagai N; Tsuyama S; Tomita S; Hirai S; Ogura K; Matsumoto T; Wada R; Yao T
    Virchows Arch; 2021 Mar; 478(3):413-426. PubMed ID: 32821969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mutation spectrum that includes GNAS, KRAS and TP53 may be shared by mucinous neoplasms of the appendix.
    Hara K; Saito T; Hayashi T; Yimit A; Takahashi M; Mitani K; Takahashi M; Yao T
    Pathol Res Pract; 2015 Sep; 211(9):657-64. PubMed ID: 26160192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinctive evaluation of nonmucinous and mucinous subtypes of bronchioloalveolar carcinomas in EGFR and K-ras gene-mutation analyses for Japanese lung adenocarcinomas: confirmation of the correlations with histologic subtypes and gene mutations.
    Sakuma Y; Matsukuma S; Yoshihara M; Nakamura Y; Noda K; Nakayama H; Kameda Y; Tsuchiya E; Miyagi Y
    Am J Clin Pathol; 2007 Jul; 128(1):100-8. PubMed ID: 17580276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GNAS is frequently mutated in both low-grade and high-grade disseminated appendiceal mucinous neoplasms but does not affect survival.
    Singhi AD; Davison JM; Choudry HA; Pingpank JF; Ahrendt SA; Holtzman MP; Zureikat AH; Zeh HJ; Ramalingam L; Mantha G; Nikiforova M; Bartlett DL; Pai RK
    Hum Pathol; 2014 Aug; 45(8):1737-43. PubMed ID: 24925222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneous mutational profile and prognosis conferred by TP53 mutations in appendiceal mucinous neoplasms.
    Zhu X; Salhab M; Tomaszewicz K; Meng X; Mathew C; Bathini V; Switzer B; Walter O; Cosar EF; Wang X; Lambert LA; Hutchinson LM
    Hum Pathol; 2019 Mar; 85():260-269. PubMed ID: 30458197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of K-ras point mutation, telomerase activity, and p53 overexpression in pancreatic tumours.
    Uemura K; Hiyama E; Murakami Y; Kanehiro T; Ohge H; Sueda T; Yokoyama T
    Oncol Rep; 2003; 10(2):277-83. PubMed ID: 12579258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular profiling of appendiceal epithelial tumors using massively parallel sequencing to identify somatic mutations.
    Liu X; Mody K; de Abreu FB; Pipas JM; Peterson JD; Gallagher TL; Suriawinata AA; Ripple GH; Hourdequin KC; Smith KD; Barth RJ; Colacchio TA; Tsapakos MJ; Zaki BI; Gardner TB; Gordon SR; Amos CI; Wells WA; Tsongalis GJ
    Clin Chem; 2014 Jul; 60(7):1004-11. PubMed ID: 24821835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leptin, MUC2 and mTOR in appendiceal mucinous neoplasms.
    Chang MS; Byeon SJ; Yoon SO; Kim BH; Lee HS; Kang GH; Kim WH; Park KJ
    Pathobiology; 2012; 79(1):45-53. PubMed ID: 22236547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.